ArticleBMC geriatrics2025
Understanding COVID-19 vaccine hesitancy among older adults in post-zero-COVID China: a predictive modeling study.
Article in BMC geriatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Upward intergenerational support and vaccination decisions among community-dwelling older adults in China: A multicenter qualitative study.Human vaccines & immunotherapeutics · 2026Article
- Dynamic trends and determinants of COVID-19 vaccine hesitancy among adults in China during 2021-2022: A multilevel analysis based on four national cross-sectional surveys.Human vaccines & immunotherapeutics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundThe inadequate vaccination rates observed in China's older population underscore the urgent need for immediate action to accelerate the immunization campaign and mitigate the consequences of adjusting the zero COVID-19 strategy.
objectiveThis study's objective was to identify key predictors of COVID-19 vaccine hesitancy among older adults in China during the post-zero-COVID period and to develop interpretable models to inform the development of targeted intervention strategies.
methodsWe conducted a cross-sectional study between January and March 2023, sampling 647 older persons across fifteen Chinese provinces. Predictors included sociodemographic characteristics, health status, psychological antecedents of vaccination, perceptions related to the COVID-19, and mental health. Group LASSO regression was employed for feature selection, followed by binary multivariable logistic regression and Random Forest modeling. SHapley Additive Explanations (SHAP) was used to illuminate the variable significance.
resultsAmong the participants, the mean age was 68.36 ± 6.26 years, and 49.9% were male. The prevalence of vaccine hesitancy was 53.3% (95% CI, 49.5%-57.2%). Significant predictors of reduced vaccine hesitancy identified in the logistic regression model included elevated confidence (β = -0.852, P < 0.001), increased fear of COVID-19 (β = -0.060, P = 0.002), and residence in the Midlands (β = -0.840, P = 0.007) or Western regions (β = -0.899, P = 0.004) relative to the Eastern region. Heightened perceived constraint (β = 0.390, P < 0.001) significantly predicted higher vaccine hesitation. The logistic regression model (AUC = 0.827) and Random Forest model (AUC = 0.808) demonstrated high predictive performance. SHAP analysis confirmed the importance of confidence, constraints, region, COVID-19 vaccination status, education level, and collective responsibility in shaping individual-level predictions.
conclusionCOVID-19 vaccine hesitancy among older adults in China is shaped by psychological attitudes, structural barriers to access, and changing risk perceptions following the post-zero-COVID strategy era. Our study demonstrates that interpretable modeling effectively identifies these key drivers, providing a clear evidence base for developing targeted public health strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.